| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kinnate Biopharma Inc. | COO GENERAL COUNSEL SECRETARY | Common Stock | 0 | $0 | $2.59 | Apr 3, 2024 | Direct |
| Kinnate Biopharma Inc. | COO GENERAL COUNSEL SECRETARY | Stock Option (right to buy) | 0 | Apr 3, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| KNTE | Kinnate Biopharma Inc. | Apr 3, 2024 | 6 | $0 | 4 | Apr 5, 2024 | COO GENERAL COUNSEL SECRETARY |
| KNTE | Kinnate Biopharma Inc. | Mar 1, 2024 | 1 | -$1.45K | 4 | Mar 5, 2024 | COO GENERAL COUNSEL SECRETARY |
| KNTE | Kinnate Biopharma Inc. | Dec 1, 2023 | 1 | -$1.22K | 4 | Dec 5, 2023 | COO General Counsel Secretary |
| KNTE | Kinnate Biopharma Inc. | Sep 1, 2023 | 1 | -$1.27K | 4 | Sep 6, 2023 | COO General Counsel Secretary |
| KNTE | Kinnate Biopharma Inc. | Jun 1, 2023 | 1 | -$2.33K | 4 | Jun 5, 2023 | COO General Counsel Secretary |
| KNTE | Kinnate Biopharma Inc. | Mar 1, 2023 | 1 | -$3.32K | 4 | Mar 3, 2023 | COO General Counsel Secretary |
| KNTE | Kinnate Biopharma Inc. | Feb 10, 2023 | 1 | $0 | 4 | Feb 14, 2023 | COO General Counsel Secretary |
| KNTE | Kinnate Biopharma Inc. | Dec 1, 2022 | 1 | -$4.19K | 4 | Dec 2, 2022 | COO General Counsel Secretary |
| KNTE | Kinnate Biopharma Inc. | Sep 1, 2022 | 1 | $0 | 4 | Sep 2, 2022 | COO General Counsel Secretary |
| KNTE | Kinnate Biopharma Inc. | Feb 11, 2022 | 1 | $0 | 4 | Feb 15, 2022 | COO General Counsel Treasurer |